Cardiovascular Systems, Inc. (CSII): Price and Financial Metrics


Cardiovascular Systems, Inc. (CSII)

Today's Latest Price: $39.34 USD

1.32 (3.47%)

Updated Jun 3 2:15pm

Add CSII to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

CSII Stock Summary

  • The price/operating cash flow metric for Cardiovascular Systems Inc is higher than 99.23% of stocks in our set with a positive cash flow.
  • The ratio of debt to operating expenses for Cardiovascular Systems Inc is higher than it is for about just 12.13% of US stocks.
  • Over the past twelve months, CSII has reported earnings growth of -319.61%, putting it ahead of only 5.34% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Cardiovascular Systems Inc, a group of peers worth examining would be CSPI, ASPN, FEIM, AMRN, and RELL.
  • CSII's SEC filings can be seen here. And to visit Cardiovascular Systems Inc's official web site, go to www.csi360.com.
CSII Daily Price Range
CSII 52-Week Price Range

CSII Stock Price Chart More Charts


CSII Price/Volume Stats

Current price $39.34 52-week high $55.22
Prev. close $38.02 52-week low $26.00
Day low $37.80 Volume 91,730
Day high $39.38 Avg. volume 310,986
50-day MA $38.13 Dividend yield N/A
200-day MA $43.51 Market Cap 1.39B

Cardiovascular Systems, Inc. (CSII) Company Bio


Cardiovascular Systems develops, manufactures, and markets devices for the treatment of vascular diseases, targeting a range of plaque types in leg arteries above and below the knee. The company was founded in 1989 and is based in St. Paul, Minnesota.

CSII Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$39.34$0.03-100%

Below please find a table outlining a discounted cash flow forecast for CSII, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Cardiovascular Systems Inc ranked in the 0th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for CSII, they are:

  • The company's compound free cash flow growth rate over the past 3.26 years comes in at -0.38%; that's greater than only 3.37% of US stocks we're applying DCF forecasting to.
  • The company has produced more trailing twelve month cash flow than only 4.92% of its sector Healthcare.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than only 6.85% of the free cash flow producing stocks we're observing.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-100%
1%-100%
2%-100%
3%-100%
4%-100%
5%-100%

AGHC, ALC, ANGO, ELAN, and HAPP can be thought of as valuation peers to CSII, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


CSII Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CSII Latest Social Stream


Loading social stream, please wait...

View Full CSII Social Stream

Latest CSII News From Around the Web

Below are the latest news stories about Cardiovascular Systems Inc that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Edited Transcript of CSII earnings conference call or presentation 5-May-20 8:30pm GMT

Q3 2020 Cardiovascular Systems Inc Earnings Call

Yahoo | May 28, 2020

Cardiovascular Systems (CSII) Reports Q3 Loss, Lower Margin

Cardiovascular Systems (CSII) witnesses a significant decline in procedure volumes in Q3 for patients treated with orbital atherectomy devices.

Zacks Investment Research | May 6, 2020

Cardiovascular Systems (CSII) Reports Q3 Loss, Lags Revenue Estimates

Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 11.11% and -4.42%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research | May 5, 2020

Cardiovascular Systems, Inc. Reports Fiscal 2020 Third-Quarter Financial Results

CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2020 THIRD-QUARTER FINANCIAL RESULTS

Yahoo | May 5, 2020

Analysts Estimate Cardiovascular Systems (CSII) to Report a Decline in Earnings: What to Look Out for

Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | April 28, 2020

Read More 'CSII' Stories Here

CSII Price Returns

1-mo -1.03%
3-mo 5.36%
6-mo -12.17%
1-year -2.84%
3-year 26.70%
5-year 36.36%
YTD -19.04%
2019 70.55%
2018 20.26%
2017 -2.15%
2016 60.12%
2015 -49.73%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.2043 seconds.